diagnóstico.
Anexos – Caracterización del Lupus Eritematoso sistémico
Anexos – Caracterización del Lupus Eritematoso sistémico
REFERENCIAS BIBLIOGRÁFICAS
1. Livingston B, Bonner A, Pope J. Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis. Lupus. Nov 2011;20(13):1345-55.
2. Petri M, Orbai AM, Alarcón GS. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. Aug 2012;64(8):2677-86.
3. Grupo de trabajo en Enfermedades Autoinmunes Sistémicas de la Sociedad Española de Reumatología. Registro nacional de pacientes con lupus eritematoso sistémico de la Sociedad Española de Reumatología: objetivos y metodología. Reumatol Clin. 2014;10(1):17–24
4. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. Dec 1 2011;365(22):2110-21.
5. Isenberg D, Appel GB, Contreras G. Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study. Rheumatology (Oxford). Jan 2010;49(1):128-40.
6. Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon N. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res (Hoboken). Feb 2012;64(2):159-68.
7. Stefanidou S, Benos A, Galanopoulou V. Clinical expression and morbidity of systemic lupus erythematosus during a post-diagnostic 5-year follow-up: a male:female comparison. Lupus. Oct 2011;20(10):1090-4.
8. Urowitz MB, Gladman DD, Ibañez Dl. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort. Arthritis Care Res (Hoboken). Jan 2012;64(1):132-7.
9. Kokuina E. Autoanticuerpos como biomarcadores de actividad de la enfermedad del lupus eritematoso sistémico. Rev Cubana Med. 2014;53(2): 201-23
10. Grupo de Estudio de Enfermedades Autoinmunes Sistémicas, Sociedad Española de Medicina Interna. Guías clínicas de enfermedades autoinmunes sistémicas. Madrid: Sociedad Española de Medicina Interna, 2011.p. 70
11. Sanchez E, Nadig A, Richardson BC, et al. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis. Oct 2011;70(10):1752-7.
12. Llerena RG, Toledano MG, Vasallo PR, Mantecón LA, Rosa LI Aguilera, Delgado FI. Estudio analítico y actualización temática de una serie de pacientes en Cuba con Lupus y embarazo. Rev Cubana Obstet Ginecol. 2009 Oct-Dic; 35(4).
13. Järvinen TM, Hellquist A, Zucchelli M. Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population. Rheumatology (Oxford). Jan 2012;51(1):87-92.
14. Ritterhouse LL, Crowe SR, Niewold TB. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis. Sep 2011;70(9):1569-74
15. Hahn BH, McMahon MA, Wilkinson A. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). Jun 2012;64(6):797-808.
16. Hanly JG, Urowitz MB, Su L. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis. Oct 2011;70(10):1726-32.
17. Mavrogeni S, Bratis K, Markussis V, Spargias C. The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis. Lupus. 2013;22(1):34-43.
18. Hwang J, Kim HJ, Oh JM. Outcome of reclassification of World Health Organization (WHO) class III under International Society of Nephrology-Renal Pathology Society (ISN-RPS) classification: retrospective observational study. Rheumatol Int. Jul 2012;32(7):1877-84
19. Bosch X. Systemic lupus erythematosus and the neutrophil. N Engl J Med. Aug 25 2011;365(8):758-60.
20. Deng Y, Tsao BP. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol. Dec 2010;6(12):683-92.
21. Sestak AL, Fürnrohr BG, Harley JB, Merrill JT, Namjou B. The genetics of systemic lupus erythematosus and implications for targeted therapy. Ann Rheum Dis. Mar 2011;70 Suppl 1:i37-43.
22. Faurschou M, Mellemkjaer L, Starklint H. High risk of ischemic heart disease in patients with lupus nephritis. J Rheumatol. Nov 2011;38(11):2400-5.
23. Bertsias GK, Ioannidis JP, Aringer M. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. Dec 2010;69(12):2074-82..
24. Varaprasad IR, Agrawal S, Prabu VN, Rajasekhar L, Kanikannan MA, Narsimulu G. Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. J Rheumatol. Aug 2011;38(8):1607-11.
25. Petri M, Naqibuddin M, Carson KA, Wallace DJ, Weisman MH, Holliday SL, et al. Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus. J Rheumatol. Oct 2010;37(10):2032-8.
26. Faurschou M, Dreyer L, Kamper AL, Starklint H, Jacobsen S. Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis. Arthritis Care Res (Hoboken). Jun 2010;62(6):873-80